News

Sarcopenia, myosteatosis, and systemic immune inflammatory index were independently associated with reduced oesophageal cancer survival in patients treated with immunotherapy, supporting their role in prognostic assessment.

A case series published in BMC Rheumatology describes new-onset inflammatory arthritis following bariatric surgery, with MRI-confirmed axial and peripheral disease requiring advanced treatment.

A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite their high cardiovascular risk.

A global report shows uneven progress toward WHO hepatitis elimination goals, highlighting persistent policy and implementation gaps in testing and treatment.

Importantly, baseline gut microbiome profiles predicted changes in glycohaemoglobin among users of both therapies.

Spending more time outdoors was linked to higher testosterone levels and lower odds of low testosterone in adult men, independent of lifestyle and metabolic factors.

Patients who responded to treatment showed increased Beta2 power, enhanced high-frequency functional connectivity, and dominant engagement of frontal brain networks.

Dasatinib plus blinatumomab demonstrated greater and sustained immune activation than ponatinib combinations in Ph+ acute lymphoblastic leukaemia, with marked effects on lymphocytes and natural killer cells.